Tim russert and sudden cardiac death after myocardial infarction Steven E. Nissen Editor’s Commentary 16 October 2008 Pages: 343 - 344
Dronedarone’s effects on atrial fibrillation Bruce B. Lerman Clinical Trials Report 16 October 2008 Pages: 349 - 350
Selective site pacing: Rationale and practical application Sameer ParekhKenneth M. Stein OriginalPaper 16 October 2008 Pages: 351 - 359
Ablation of atrial fibrillation: Patient selection, technique, and outcome Steven M. Markowitz OriginalPaper 16 October 2008 Pages: 360 - 366
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: An update Hugh CalkinsFrank Marcus OriginalPaper 16 October 2008 Pages: 367 - 375
Brugada syndrome: Recent advances and controversies Charles AntzelevitchEyal Nof OriginalPaper 16 October 2008 Pages: 376 - 383
Current concepts in the evaluation and management of syncope Vikas KuriachanRobert S. Sheldon OriginalPaper 16 October 2008 Pages: 384 - 390
Putting the benefits of percutaneous coronary revascularization into perspective: From trials to guidelines Kamal SharmaMark J. Eisenberg OriginalPaper 16 October 2008 Pages: 393 - 401
The risks and benefits of drug-eluting stents in the setting of STEMI Rosetta MelfiAnnunziata NuscaGermano Di Sciascio OriginalPaper 16 October 2008 Pages: 402 - 406
Percutaneous coronary intervention without onsite surgical backup Gregory J. Dehmer OriginalPaper 16 October 2008 Pages: 407 - 414
Reperfusion options in ST-elevation myocardial infarction patients with expected delays David M. LarsonTimothy D. Henry OriginalPaper 16 October 2008 Pages: 415 - 423
GP IIb/IIIa inhibitors during primary percutaneous coronary intervention for STEMI: New trial and registry data Umesh U. TamhaneHitinder S. Gurm OriginalPaper 16 October 2008 Pages: 424 - 430